Science 37
Allan Badulis currently serves as the Director of Strategic Solutions at Science 37, leading initiatives to implement scalable, patient-centric solutions for clinical trials. Previously, Allan held the position of Director of Global Research Business at NIOX®, where responsibilities included developing a successful global commercial strategy that resulted in double-digit revenue growth. Before that, Allan was the Director of Sales and Strategic Planning at Sobi - North America, providing expertise in rare diseases and optimizing systems to enhance sales productivity. As Regional Sales Director at Melinta Therapeutics, Allan achieved a remarkable turnaround in an under-performing region, attaining the #1 national rank shortly after assuming the role. Allan also has experience as Director of Business Development at Target RWE Health Evidence Solutions, where growth was revitalized through strategic partnerships. Allan holds a Bachelor of Science degree in Psychology from the University of South Florida.
This person is not in any teams
This person is not in any offices
Science 37
2 followers
Science 37 is making the promise of virtual trials the new reality. By engaging with patients from the comfort of their own home, the company provides access to patients who can never be reached by traditional site-based research models. Its virtual model has proven to enroll faster, retain patients at a higher rate, and reach a more representative patient population. Science 37 has conducted more virtual (or decentralized), interventional trials than any other company, using an expansive, in-house network of telemedicine investigators and home-health nurses. The company's research is powered by the industry’s most comprehensive, fully integrated clinical trial platform purpose-built to conduct virtual trials.